New Research: Key Drivers of Growth for ON Semiconductor, Entegris, Universal, MarineMax, Epizyme, and Merrimack Pharmaceuticals — Factors of Influence, Major Initiatives and Sustained Production
February 12, 2019 07:35 ET | Fundamental Markets
NEW YORK, Feb. 12, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders,...
Fact.MR.jpg
Natural Cold, Cough and Sore Throat Remedies Gain Popularity Despite Ambiguity over Effectiveness, finds Fact.MR study
February 12, 2019 07:34 ET | Fact.MR
Rockville, MD, Feb. 12, 2019 (GLOBE NEWSWIRE) -- According to a recent study of Fact.MR, the natural cold, cough, and sore throat remedies market is expected to surpass revenues worth US$ 4,800 Mn...
logo.png
Global Credit Insurance Market Report 2019: Trends, Forecast and Competitive Analysis 2013-2023
February 12, 2019 07:31 ET | Intense Research
Deerfield Beach,Florida, Feb. 12, 2019 (GLOBE NEWSWIRE) -- The report gives a detailed overview of Global "Credit Insurance Market 2018” and predicts future market trends throughout the forecast...
BW Offshore: Invitation to Q4 2018 Presentation 19 February
February 12, 2019 07:30 ET | BW Offshore
BW Offshore will release its Annual Report 2018 and the Q4 2018 results on Tuesday 19 February at 07:30 (CET). The company will host a presentation of the financial results 09:00 (CET) the same...
logo.jpg
Invitation to Presentation of SimCorp’s Annual Report 2018
February 12, 2019 07:30 ET | SimCorp A/S
PRESS RELEASE SimCorp will publish its Annual Report 2018 to NASDAQ Copenhagen on Wednesday, February 20, 2019 at around 8:00 am (CET). SimCorp’s Executive Management Board will present the...
55a92bd87a0c9f0009767c70_logo.jpg
Hemp, Inc. CEO Featured by ABC15 Arizona Discussing Hemp Regulatory Updates and Veteran Village Kins Community
February 12, 2019 07:30 ET | Hemp, Inc.
SPRING HOPE, NC, Feb. 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Hemp, Inc. (OTC PINK: HEMP) a global leader in the industrial hemp industry, Hemp, Inc. has industrial hemp processing centers...
provectus_logo.jpg
PROVECTUS ANNOUNCES GRANT OF ORPHAN DRUG DESIGNATION IN U.S. TO PV-10 FOR TREATMENT OF OCULAR MELANOMA
February 12, 2019 07:30 ET | Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that orphan drug designation (ODD) status was granted by the U.S. Food and Drug Administration (FDA) to small...
Pacira_logo[1].JPG
Pacira Expands EXPAREL Manufacturing Capacity to Meet Growing Demand
February 12, 2019 07:30 ET | Pacira Pharmaceuticals, Inc.
PARSIPPANY, N.J., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that commercial production of EXPAREL® (bupivacaine liposome injectable suspension) is...
Parkinson’s Disease: ProMIS Neurosciences Identifies Several Antibody Drug Candidates Showing Best-in-Class Selectivity for Toxic Forms of Alpha-Synuclein Compared to other Therapeutic Antibodies in Development
February 12, 2019 07:30 ET | ProMIS Neurosciences Inc.
TORONTO and CAMBRIDGE, Mass., Feb. 12, 2019 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody...
canntab_therapeutics_logo.png
Canntab Enters into Supply Agreement with FSD Pharma and World Class Extractions on Organic Hemp Deal
February 12, 2019 07:30 ET | Canntab Therapeutics Limited
TORONTO, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Canntab Therapeutics Limited (CSE: PILL, FSE: TBF1) (“Canntab”), a leader in the development of precision oral dose cannabis tablets and capsules,...